Home > Boards > Free Zone > Health and Sciences > Biotech Values

ABBV-AGN PR on $63B buyout:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 764
Posts 117,707
Boards Moderated 16
Alias Born 09/05/02
160x600 placeholder
Corn Leads Grain Rally Fueled by Bullish Weather -- Daily Grain Highlights
By Paulo Trevisani
Front Month Nymex Natural Gas Rose 22.66% This Week to Settle at $4.6390 -- Data Talk
Front Month Nymex RBOB Gasoline Rose 4.09% This Week to Settle at $2.5423 -- Data Talk
Treasury Considers Alternatives to ID.me Verification Citing Privacy Concerns, Bloomberg News Reports
Caterpillar Down Over 6%, Worst Performer in the DJIA So Far Today -- Data Talk
Chevron on Pace for Largest Percent Decrease Since September 2020 -- Data Talk
Mastercard Up Over 6%, on Pace for Largest Percent Increase Since November 2020 -- Data Talk
Unemployment Rate Seen Holding at 3.9% -- Data Week Ahead
Top Company News of the Day
STOXX Europe 600 Index Ends the Week 1.87% Lower at 465.55 -- Data Talk
FTSE 100 Index Ends the Week 0.37% Lower at 7466.07 -- Data Talk
DAX Ends the Week 1.83% Lower at 15318.95 -- Data Talk
CAC 40 Index Ends the Week 1.45% Lower at 6965.88 -- Data Talk
STOXX Europe 50 Index Ends the Week 1.35% Lower at 3730.93 -- Data Talk
EURO STOXX 50 Index Ends the Week 2.19% Lower at 4136.91 -- Data Talk
Lilly to Invest $1 Billion on New Manufacturing Plant in N.C.
FTSE 100 Closes Lower on Inflation, Rising Interes Rates
Kansas City Fed Services Activity Index Rises in January
Apple Up Over 5%, on Track for Largest Percent Increase Since October 2020 -- Data Talk
Intel on Track for Lowest Close Since December 2020 -- Data Talk
Visa Up Over 5%, on Pace for Largest Percent Increase Since November 2020 -- Data Talk
Oil Prices Seen at $78 This Year as Supply Hikes Lag Demand
US Consumer Sentiment Wanes in Late January to Decade-Low on Inflation Concerns
Insulet Shares Rally on FDA Approval of Omnipod 5
Provention Bio Shares Rise 13% After Plan to Resubmit BLA
Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung Cancer
Citi Works With Five Black-Owned Firms on Bond Issuance
U.S. Consumer Spending Fell 0.6% in December
Eli Lilly Reports Olumiant Setbacks in Lupus, Atopic Dermatitis
FTSE Down, Long Gilts Could Remain in Sweet Spot
Colgate-Palmolive Expects Earnings Growth This Year
Chevron Hits Production High in 2021, Net Output Down 5% in 4Q -- Energy Comment
DewDiligence Member Level  Tuesday, 06/25/19 09:58:30 AM
Re: biocqr post# 225375
Post # of 241362 
ABBV-AGN PR on $63B buyout:

https://finance.yahoo.com/news/abbvie-acquire-allergan-transformative-move-104200213.html
Quote:
Under the terms of the Transaction Agreement, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan…for a total consideration of $188.24 per Allergan Share [based on ABBV’s 6/24/19 closing price]. The transaction represents a 45% premium to the closing price of Allergan's Shares on June 24, 2019.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences